This inventor holds 2 USPTO granted patents. Top assignee: American Regent, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Innovator Spotlight: Saral Pinkal Patel and His Contributions to Pharmaceutical Science
Introduction: Saral Pinkal Patel is a prominent inventor based in Powell, Ohio, specializing in pharmaceutical compositions. With a focus on innovative solutions for cardiovascular disorders, Patel has made significant strides with his patented invention which plays a critical role in medicinal chemistry.
Latest Patents: Patel holds a patent for "1,4-dihydropyridine compositions, methods of making and use". This patent presents pharmaceutical compositions that consist of a class of calcium channel blockers combined with at least one chelating agent. Specifically, it features compositions that include various 1,4-dihydropyridine (DHP) compounds paired with chelating agents, which serve to enhance the stability of these compositions. The unique formulation aims to treat cardiovascular disorders effectively and ensures prolonged stability over time.
Career Highlights: Saral Pinkal Patel currently works at American Regent, Inc., where he applies his expertise in pharmaceutical development. His role has allowed him to contribute meaningfully to the company's focus on advancing healthcare solutions and improving patient outcomes through innovative drug formulations.
Collaborations: Throughout his career, Patel has collaborated with noteworthy professionals in his field, including Daniel Walter Wehrung and Meng Zhong. These partnerships have facilitated the exchange of knowledge and expertise, leading to the development of advanced pharmaceutical products.
Conclusion: Saral Pinkal Patel exemplifies the innovative spirit of modern inventors in the pharmaceutical industry. His groundbreaking patent for 1,4-dihydropyridine compositions showcases his commitment to addressing critical health challenges, particularly in cardiovascular medicine. As his career progresses, the impact of his work at American Regent, Inc. and collaborations with fellow researchers are set to continue shaping the future of pharmaceutical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile